HealthEquity Reports Third Quarter Ended October 31, 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Raymond James Downgrades HealthEquity, Inc (HQY) to Outperform
December 7, 2021 7:14 AM ESTRaymond James analyst C. Gregory Peters downgraded HealthEquity, Inc (NASDAQ: HQY) from Strong Buy to Outperform with a price target of $70.00 (from $90.00) following results.
The analyst commented, "The stock was down over 20% after hours last night as management lowered guidance (see page 2 for changes in guidance) for FY22 due in part to disappointing Service and Interchange revenue results. Service revenue declined 1.7% y/y to $103M in... More
HealthEquity (HQY) Reports In-Line Q3 EPS, FY EPS Guidances Misses Consensus
December 6, 2021 4:03 PM ESTHealthEquity (NASDAQ: HQY) reported Q3 EPS of $0.35, in-line with the analyst estimate of $0.35. Revenue for the quarter came in at $180 million versus the consensus estimate of $185.05 million.
GUIDANCE:
HealthEquity sees FY2022 EPS of $1.30-$1.35, versus the consensus of $1.48. HealthEquity sees... More
